![ECOG-ACRIN logo[19516]275×75](https://blog.ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
July 31, 2026
An update on our NCTN grant award, practice-changing multiple myeloma research, a promising new lung cancer study, and highlights from the Comis Translational Science Symposium
July 31, 2026
ECOG-ACRIN’s Trial Results Summaries Project informs clinical trial participants of study findings, recognizes their vital contributions, and fosters a spirit of partnership in cancer research
July 31, 2026
This phase 2 study is evaluating ivonescimab, a novel therapy designed to target the PD-1 and VEGF pathways simultaneously
July 31, 2026
The latest findings in breast cancer, cardiotoxicity, leukemia, lung cancer, myeloma, NCI-MATCH, and smoking cessation support during cancer treatment
July 31, 2026
Timely information about research presented at medical meetings, recognition of research leaders, and more
June 29, 2026
An update on federal funding and policy developments shaping the future of cancer research
June 29, 2026
The latest findings in brain tumors, breast cancer, kidney cancer, lung cancer, Merkel cell carcinoma, and precision oncology
May 28, 2026
A recap of the Spring 2026 Group Meeting and reflections on addressing distrust in science
May 28, 2026
The latest findings in breast cancer, cardiotoxicity, leukemia in older adults, and reproductive health management for cancer patients of childbearing age
April 24, 2026
A preview of the upcoming Spring Group Meeting, a recap of AACR 2026, and an update on the current state of the NCI's cancer research efforts
April 24, 2026
The latest clinical trial findings in breast cancer, cancer control and survivorship, health equity, leukemia, melanoma, and NCI-MATCH
March 30, 2026
The co-chairs reflect on the rapidly evolving definition of sensitive research data and highlight priorities for building secure data environments that sustain patient protection and public trust